Pharmaceuticals
The surge in dengue cases across the region has been a growing concern
Takeda Pharmaceutical reports an 11-fold increase in dengue cases in India over the past two decades. © Reuters
MUMBAI — India has approved Takeda Pharmaceutical’s dengue vaccine, its first of its kind, to combat the surging spread of the disease. The new authorization marks a critical step in addressing public health challenges posed by the mosquito-borne illness.
